RE:News release roadmap (expected)I don't believe Valeant skin lightening on the shelves on Q2'15. I guess not before Q1'16.
forhandlaren wrote: In terms of upcoming news releases I expect the following - not to mention new compounds not currently known to the public. The timing of NR is of course very difficult to foresee, but nevertheless Sirona should be able to produce these NR in the following months. I expect at least one SP pop to one dollar during the period of time, and a sustainable SP of 50 cents before the years end (2015).
Q1 ‘15
skin lightener TFC-1067 performance (minor SP impact) (announced on/before March 11th)
anti-aging update (minor SP impact) (announced) (announced on/before March 11th)
SGLT2 update (minor SP impact) (announced) (announced on/before March 11th)
Q2 ‘15
Valeant skin lightning products on the shelves (major SP impact)
SGLT2 into Phase I (minor SP impact)
Q3 ‘15
SGLT2 ROW licensing deal (major SP impact)
anti-inflammatory Bloom Burton into Phase I (minor SP impact)
Q4 ‘15
cash-flow Valeant deal (major SP impact)
anti-aging licensing deal (major SP impact)
Q1-Q2 ‘16
skin lightening licensing deal non-Valeant (major SP impact)
sunscreen licensing deal (major SP impact) dependency to the anti-aging program
cancer antigen licensing deal (major SP impact)
crop licensing deal Aegilops (minor SP impact)
vaccine preservation licensing deal VitamFero (minor SP impact) dependency to the anti-aging program
anti-infective Bloom Burton into Phase I (minor SP impact)